Evidence map›Paper›PMID 33489300›Full record

ArticleRoyal Society open science2020

Vitamin D and COVID-19: evidence and recommendations for supplementation.

George Griffin, Martin Hewison, Julian Hopkin, Rose Kenny, Richard Quinton, Jonathan Rhodes, Sreedhar Subramanian, David Thickett

Open access · goldAbstract read
In one paragraph

Article in Royal Society open science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 6 pooled it
10.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 6 syntheses or guidelines pooled it, 81 citations in OpenAlex.

  1. Pooled it
  2. Does vitamin D supplementation reduce COVID-19 severity?: a systematic review.QJM : monthly journal of the Association of Physicians · 2022
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Vitamin D supplementations and mortality among patients with moderate/severe COVID-19: A meta-analysis of randomized controlled trials.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2024
    Review
  16. Article
  17. Vitamin D supplementation in a post-pandemic era: A narrative review.South African family practice : official journal of the South African Academy of Family Practice/Primary Care · 2023
    Review
  18. Article
  19. Vitamin D and COVID-19: where are we now?Postgraduate medicine · 2023
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 2 countries.

George GriffinInfectious Diseases and Medicine, St George's University of London, London, UK.
Martin HewisonInstitute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK.
Julian HopkinMedical School, Swansea University, Swansea, West Glamorgan, UK.
Rose KennyMedical Gerontology, Trinity College Dublin School of Medicine, Dublin, Ireland.
Richard QuintonEndocrinology, Newcastle University Faculty of Medical Sciences, Newcastle upon Tyne, UK.
Jonathan RhodesInstitute of Translational Medicine, University of Liverpool, Liverpool, UK.ORCID 0000-0002-1302-260X
Sreedhar SubramanianGastroenterology, Royal Liverpool University Hospital, Liverpool, UK.
David ThickettInstitute of Inflammation and Ageing, University of Birmingham College of Medical and Dental Sciences, Birmingham, UK.
University of Birmingham · GBUniversity of Liverpool · GBNewcastle University · GBSt George's, University of London · GBSwansea University · GBTrinity College Dublin · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vitamin D is a hormone that acts on many genes expressed by immune cells. Evidence linking vitamin D deficiency with COVID-19 severity is circumstantial but considerable-links with ethnicity, obesity, institutionalization; latitude and ultraviolet exposure; increased lung damage in experimental models; associations with COVID-19 severity in hospitalized patients. Vitamin D deficiency is common but readily preventable by supplementation that is very safe and cheap. A target blood level of at least 50 nmol l

Indexed as

COVID-19immunologyvitamin D

Identifiers

PMID33489300
PMCPMC7813231
OpenAlexW3107507380

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.